Onderneming Boule Diagnostics AB Nasdaq Stockholm
Aandelen
SE0000437402
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Consumables to Own Instruments
40,8
%
| 233 | 42,5 % | 233 | 40,8 % | +0,16% |
Instruments
32,1
%
| 159 | 28,9 % | 184 | 32,1 % | +15,78% |
Consumable Original Equipment Manufacturer and Clinical Diagnostic Solutions-Brand
20,0
%
| 113 | 20,5 % | 114 | 20,0 % | +1,32% |
Other
7,1
%
| 44 | 8,0 % | 40 | 7,1 % | -8,21% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
34,9
%
| 190 | 34,6 % | 199 | 34,9 % | +4,92% |
Asia
29,6
%
| 151 | 27,5 % | 169 | 29,6 % | +12,35% |
Africa/ Middle East
10,8
%
| - | - | 62 | 10,8 % | - |
Latin America
9,0
%
| 45 | 8,2 % | 52 | 9,0 % | +14,52% |
Western Europe
8,9
%
| 40 | 7,2 % | 51 | 8,9 % | +28,08% |
Eastern Europe
6,8
%
| 62 | 11,4 % | 39 | 6,8 % | -38,05% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 01/01 |
Aishat Bislieva
HRO | Human Resources Officer | - | 01-10-22 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 01-01-12 |
Debbie Herrera
LAW | General Counsel | - | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 01-01-21 | |
Chairman | 72 | 01-01-21 | |
Director/Board Member | 57 | 01-01-14 | |
Director/Board Member | 65 | 01-01-15 | |
Emil Hjalmarsson
BRD | Director/Board Member | 35 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 833 104 | 23 948 273 ( 61,67 %) | 0 | 61,67 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,00% | 185 mld. | |
+31,86% | 158 mld. | |
+33,21% | 113 mld. | |
+2,28% | 64,32 mld. | |
+21,14% | 55,66 mld. | |
+0,11% | 48,41 mld. | |
-6,76% | 37,82 mld. | |
+0,78% | 35,57 mld. | |
+11,28% | 28,12 mld. |